European Agencies Launch Actos Safety Probe

Experts at the London-based European Medicines Agency (EMA) are scheduled to look at the risk and benefits of Actos, a popular prescription medication for type 2 diabetes. In its generic form, the drug is known as pioglitazone. Actos is part of a class of drugs called thiazolidinediones or TZDs. Among the drugs in the same [...]